Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK16149 vs Pregabalin in Herpetic Neuralgia
NCT05763550Phase 2Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Feb 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of crisugabalin besilate in postherpetic neuralgia (PHN), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Feb 2023; status: completed.
02
Drugs
crisugabalin besilate
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT05763550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05763550.